TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 312 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $418 | -1.4% | 27,000 | 0.0% | 0.18% | +2.9% |
Q2 2023 | $424 | -4.7% | 27,000 | 0.0% | 0.17% | -11.3% |
Q1 2023 | $445 | +5.7% | 27,000 | 0.0% | 0.19% | -1.5% |
Q4 2022 | $421 | -99.9% | 27,000 | 0.0% | 0.20% | +5.9% |
Q3 2022 | $350,000 | -8.9% | 27,000 | -1.4% | 0.19% | -5.1% |
Q2 2022 | $384,000 | -0.8% | 27,372 | +1.4% | 0.20% | +10.7% |
Q1 2022 | $387,000 | +5.2% | 27,000 | 0.0% | 0.18% | +9.3% |
Q4 2021 | $368,000 | -26.8% | 27,000 | -12.1% | 0.16% | -32.5% |
Q3 2021 | $503,000 | -2.7% | 30,700 | 0.0% | 0.24% | -1.2% |
Q2 2021 | $517,000 | -36.7% | 30,700 | -31.4% | 0.24% | -49.4% |
Q1 2021 | $817,000 | +0.4% | 44,726 | 0.0% | 0.48% | -9.3% |
Q4 2020 | $814,000 | +2.0% | 44,726 | 0.0% | 0.53% | -11.8% |
Q3 2020 | $798,000 | -0.5% | 44,726 | 0.0% | 0.60% | -7.6% |
Q2 2020 | $802,000 | +18.1% | 44,726 | 0.0% | 0.65% | -3.9% |
Q1 2020 | $679,000 | -23.0% | 44,726 | 0.0% | 0.68% | +3.8% |
Q4 2019 | $882,000 | – | 44,726 | – | 0.65% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Glenview Capital Management | 16,104,222 | $294,063,000 | 4.98% |
GMT CAPITAL CORP | 2,468,695 | $45,078,000 | 3.31% |
MANAGED ASSET PORTFOLIOS, LLC | 1,065,756 | $19,461,000 | 3.13% |
Blackcrane Capital, LLC | 14,571 | $1,723,000 | 2.72% |
BFAM Partners (Cayman) Ltd | 328,690 | $6,002,000 | 2.36% |
Paulson & Co. | 4,727,415 | $86,323,000 | 1.98% |
Mondrian Investment Partners LTD | 3,510,404 | $59,677,000 | 1.28% |
Lumbard & Kellner, LLC | 135,550 | $2,264,000 | 0.80% |
DAVIDSON INVESTMENT ADVISORS | 500,203 | $9,134,000 | 0.78% |
TFG Asset Management GP Ltd | 589,390 | $10,762,000 | 0.77% |